ANGELA CHRISTIANO^^Richard and Mildred Rhodebeck Professor of Dermatology and Professor of Genetics and Development, CUMC Vice Chair of Research, Department of Dermatology, CUMC
Angela Christiano is a Richard and Mildred Rhodebeck Professor of Dermatology and Professor of Genetics and Development, CUMC Vice Chair of Research, Department of Dermatology, CUMC.
For the past 20 years, Dr. Christiano's research has focused on understanding the molecular processes that lead to inherited skin and hair disorders in humans. Her research career began with the discovery of genetic mutations associated with epidermolysis bullosa, a skin disease that causes severe blistering. Dr. Christiano’s recent work has focused on the investigation of the underlying genetic causes of and identification of potential therapies for alopecia areata, an autoimmune form of hair loss. She has published more than 300 papers in peer-reviewed journals and has trained more than 50 postdoctoral researchers and clinical fellows at Columbia University through the Program in Genetics & Development, the Institute of Human Nutrition, the Integrated Program in Cellular, Molecular and Biomedical Studies in the Graduate School of Arts & Sciences, the Clinical and Translational Science Award Program, the Stem Cell Training Program. Dr. Christiano has received numerous awards, including the New York City Mayor’s Award for Excellence in Science and Technology – Young Investigator’s Award, Columbia University’s Harold and Golden Lamport Research Award for Excellence in Clinical Sciences, the CERIES Research Award, and the North American Hair Research Society’s award for Outstanding Paper of the Year, the Montagna Award from the Society for Investigative Dermatology, and the Ebling Award from the European Hair Research Society. Dr. Christiano is Immediate Past President of the Society for Investigative Dermatology, and served as Deputy Editor of the Journal of Investigative Dermatology for ten years. Dr. Christiano is a prolific inventor and serial entrepreneur, having filed numerous patents on her discoveries, and successfully moved technologies from the academic setting into the commercial sector. She has co-founded several companies in the dermatology space, including Skinetics Bioscience (RNAi-based dermatology therapeutics, acquired by Sirna Therapeutics, which was acquired by Merck & Co. in 2007), Vixen Pharmaceuticals (JAK inhibitors for treatment of hair disorders, acquired by Aclaris Therapeutics in 2016), and Rapunzel Bioscience, focused on regenerative therapies and stem cell approaches for skin and hair disorders. She earned her MS and PhD degrees in Microbiology and Molecular Genetics from Rutgers University.